搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
KQED
22 小时
How a Court Ruling Affects California Stem Cell Clinics That Use Unproven Therapies
The decision, experts say, reasserts the FDA’s authority over regenerative medicine at a time when clinics advertising these ...
Emporia Gazette
1 天
Knee Pain Caused by Osteoarthritis
Knee pain is one of the most common ailments that brings patients into our office each day–more specifically, osteoarthritis ...
Managed Healthcare Executive
2 天
Exploring Key Unmet Needs in Idiopathic Pulmonary Fibrosis
Paul W. Noble, M.D., of Cedars-Sinai in Los Angeles, and Paul Frohna, M.D., Ph.D., of Endeavor BioMedicines, discussed the ...
The Times of Northwest Indiana
2 天
Chiropractic care can help pets with everything from injuries to age-related issues
It all started 14 years ago with mobility-improving surgical rehab for Jake, the senior Golden Retriever. That's when Tom and ...
rheumatologyadvisor
2 天
Patient Perspectives: Finding Grace While Living With Rheumatoid Arthritis
This interview features Talisa King, who shared her experience navigating the health care system and living with rheumatoid ...
dermatologyadvisor
2 天
Targeted Therapies for PsA Cut Concomitant Medications and Healthcare Utilization
Targeted therapies for PsA are effective for reducing the use of symptomatic treatments, sick leave, and rates of hospitalization.
3 天
Rheumatoid arthritis tied to heavy economic and human burdens
Rheumatoid arthritis (RA) is associated with higher health care expenditures and suboptimal quality of life in U.S. adults, ...
News Medical
3 天
Identifying DDI risks in immunomodulators through CYP suppression studies
Learn about CYP suppression, immunomodulators, and how to identify DDR risks using studies on CYP suppression.
TMCnet
3 天
DeepCure to Present In Vivo Data Showing Its Selective BRD4 (BD2) Inhibitor DC-9476 is ...
DeepCure, a therapeutics company using AI to discover novel drugs for inflammation and immune diseases, today announced it will present data showing its selective BRD4 (BD2) inhibitor DC-9476 is ...
The New England Journal of Medicine
3 天
Avoiding Rash Decisions
A 40-year-old man presented to the emergency department with a 5-day history of fevers, sore throat, fatigue, subjective ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈